During the 2023 Skin of Color Update in New York City, esteemed experts, Dr. Andrew Alexis, Professor of Clinical Dermatology at Weill Cornell Medical College, and Dr. George Han, Associate Professor in the Department of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, shared their expertise in diagnosing and managing psoriasis in individuals with skin of color. The broad range in presentation of psoriasis in skin of color has only recently gained attention and may have played a crucial role in potential underdiagnosis and delays in administering appropria ..read more

Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Pearl E. Grimes, symposium chair and clinical professor of dermatology at the University of California, Los Angeles. Hear the “why” behind the Pigmentary Disorders Exchange Symposium from its founding chair. Learn what Dr. Grimes believes is a common myth about pigmentary disorders. Plus hear what makes the symposium a unique offering in dermatology.  Further Reading If you want to read about the dermatologic conditions addressed at the Pigmentary Disorders Exchange Symposium, check out the follow ..read more

Which of the following cells is most responsible for producing the pictured skin lesions? A. Macrophages B. Lymphocytes C. Mast cells D. Neutrophils E. Eosinophils To find out the correct answer and read the explanation, click here. Adam Smith’s famous book, The Wealth of Nations, published in Great Britain in 1776, distinguished between the outputs of what he termed “productiv The post Skin Lesions -Friday Pop Quiz 5/3/2024 appeared first on Next Steps in Dermatology ..read more

At the 2024 ODAC Dermatology, Aesthetic & Surgical Conference, we were lucky to learn about the management of chronic spontaneous urticaria (CSU) from the renowned researcher and clinician, Dr. Adam J. Friedman, Professor and Chair of Dermatology at The George Washington University School of Medicine and Health Sciences. CSU can be a frustrating, exhausting condition for patients to endure, with no identifiable triggers and a relapsing disease course. Caring for CSU requires particularly strong patient-provider trust, given that symptoms are often absent during the clinical visit and that ..read more

Derm In-Review, one of the top dermatology board review prep courses, is now going on the road. The Dermatology In-Review Live Board Review Workshop is a new, in-person event to help dermatology residents prepare for the board exam. In the past four months, residents in the Miami and New Orleans areas have attended the workshops, which were inspired by the Krazy Kodachrome sessions held at the GW Dermatology Residency Program and streamed online. “Coke had it right: You can’t beat the real thing,” said Adam Friedman, MD, Derm In-Review’s senior editor and dermatology residency program directo ..read more

Mainstream medical dermatology is changing, and it’s about time, says Dr. R. Rox Anderson, professor at Harvard Medical School and director of the Wellman Center for Photomedicine at Massachusetts General Hospital. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Anderson about the future of product innovation. Hear what Dr. Anderson thinks of the future of biologics. Learn how the future of lasers could mean a cure acne and safer treatment for people with darker skin tones. Find out how new drugs and devices can create effective t ..read more

A 65-year-old patient presents with this painful, itchy rash on the right dorsal foot. The pain has made ambulating difficult. Prior unsuccessful treatments included topical betamethasone and clotrimazole. Based on the image provided, which of the following treatments have the highest cure rate? A. Oral itraconazole B. Oral terbinafine C. Topical ciclopirox nail lacquer D. Topical efinaconazole E. Oral ketoconazole To find out the correct answer and read the explanation, click here. The post Friday Pop Quiz 04/26/2024 appeared first on Next Steps in Dermatology ..read more

Ciclopirox is the only hydroxypyridone antifungal agent with a unique mechanism of action differentiating it from other antimycotic agents. Unlike the azole-antifungals which block the sterol synthesis in the fungal cell membrane, ciclopirox functions by chelating cations resulting in the degradation of fungal cells, as well as proposed anti-inflammatory properties. It is available in a variety of formulations and its safety profile allows for expansion of its utilization targeting dermatophytes, Candida albicans, and Malassezia furfur. We continue our series, Therapeutic Cheat Sheet, with a ..read more

Tranexamic acid is one of the latest therapies for treating melasma, and one that’s most commonly prescribed for women. An editorial published in the April issue of the Journal of Drugs in Dermatology encourages dermatology clinicians to also consider the effect melasma has on men and to utilize tranexamic acid as a treatment option. I interviewed the authors, dermatologist and Mohs surgeon Andrea Hui Austin, MD, and Nicole Chin, BS, to find out what dermatology clinicians should know about treating melasma in men. This is the first dermatology study that I can remember that specifically addr ..read more

Treatment with a q-switched laser targeting which of the following wavelengths, in nm, is most appropriate to remove a majority of the shown tattoo? A. 310 B. 532 C. 755 D. 1064 E. 1450 To find out the correct answer and read the explanation, click here. The post Laser Treatment – Friday Pop Quiz 4/19/2024 appeared first on Next Steps in Dermatology ..read more